MedTrace Logo

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

NCT00744445 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2008-09-01

No results posted yet for this study

Summary

The purpose of this research study was to determine if the activity of erythropoietin (r-HuEPO) is time dependent when given to chronic renal failure patients at three different times of day.

Conditions

  • Hemodialysis
  • Chronic Renal Failure
  • Anemia

Interventions

DRUG

r-HuEPO

r-HuEPO 50 U/kg s.c. three times per week. The dose is rounded to the nearest 2000 unites.

Sponsors & Collaborators

  • Sunnybrook Health Sciences Centre

    lead OTHER

Principal Investigators

  • Georg Bjarnason, MD, FRCPC · Sunnybrook Health Sciences Centre

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1993-10-31
Primary Completion
1998-08-31
Completion
1998-08-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00744445 on ClinicalTrials.gov